Jingya Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jingya Lu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ailing Hu
Department of Personalized Kampo Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
5 shared publications - Hiroyuki Kobayashi
Department of Hospital Administration, Juntendo University Graduate School of Medicine, Tokyo, Japan
5 shared publications - Takuji Yamaguchi
Department of Personalized Kampo Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
5 shared publications - Yasushi Ikarashi
Department of Personalized Kampo Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
5 shared publications - Zenji Kawakami
Department of Personalized Kampo Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
4 shared publications - Yi Luo
Department of Personalized Kampo Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
3 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1097
Boiogito Ameliorates Hydrogen Peroxide-Induced Impairment of Glucose Uptake in 3T3-L1 Adipocytes
Chronic inflammation and oxidative stress in obese adipose tissue are pivotal drivers of insulin resistance and metabolic dysfunction. We previously demonstrated that the Kampo formula Boiogito (BOT) ameliorates impaired adipocyte differentiation and inflammation by inhibiting the nuclear factor kappa B (NF-κB) pathway in a tumor necrosis factor–alpha (TNF-α)-induced model. However, the specific effects of BOT on oxidative stress and glucose uptake remain to be elucidated. This study aimed to elucidate whether BOT could ameliorate hydrogen peroxide (H2O2)-induced oxidative stress, inflammation, and cellular dysfunction in 3T3-L1 adipocytes, thereby restoring impaired glucose uptake capacity. Differentiating and mature 3T3-L1 adipocytes were treated with 200 µM H2O2 alone or in combination with BOT (0.25 and 0.5 mg/mL). Oxidative stress markers (reactive oxygen species [ROS] and superoxide dismutase [SOD]), inflammatory cytokines (interleukin-6 [IL-6], monocyte chemoattractant protein-1 [MCP-1], and TNF-α), differentiation/functional markers (peroxisome proliferator-activated receptor gamma [Pparγ] and CCAAT/enhancer-binding protein alpha [C/ebpα] mRNA expression, adiponectin secretion, and intracellular lipid content), and glucose uptake (via a 2-deoxy-D-glucose [2-DG] assay) were evaluated. In both stages of adipocytes, H2O2 exposure significantly increased ROS levels and decreased SOD activity, and elevated extracellular IL-6, MCP-1, and TNF-α concentrations. These alterations were significantly attenuated by BOT co-treatment. Furthermore, BOT prevented the H2O2-induced downregulation of Pparγ and C/ebpα mRNA expression, thereby restoring adiponectin secretion and intracellular lipid content. Crucially, the marked impairment of 2-DG uptake caused by H2O2-mediated metabolic stress was significantly reversed by BOT co-treatment. These findings suggest that BOT exerts multi-targeted protective effects in 3T3-L1 adipocytes by mitigating oxidative stress, suppressing inflammation, and preserving adipocyte differentiation and function, thereby restoring impaired glucose uptake. Our study provides new insights into the therapeutic potential of BOT against insulin resistance and associated metabolic disorders.
- 22 October 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1097
Open AccessBoiogito Ameliorates Hydrogen Peroxide-Induced Impairment of Glucose Uptake in 3T3-L1 Adipocytes
Chronic inflammation and oxidative stress in obese adipose tissue are pivotal drivers of insulin resistance and metabolic dysfunction. We previously demonstrated that the Kampo formula Boiogito (BOT) ameliorates impaired adipocyte differentiation and inflammation by inhibiting the nuclear factor kappa B (NF-κB) pathway in a tumor necrosis factor–alpha (TNF-α)-induced model. However, the specific effects of BOT on oxidative stress and glucose uptake remain to be elucidated. This study aimed to elucidate whether BOT could ameliorate hydrogen peroxide (H2O2)-induced oxidative stress, inflammation, and cellular dysfunction in 3T3-L1 adipocytes, thereby restoring impaired glucose uptake capacity. Differentiating and mature 3T3-L1 adipocytes were treated with 200 µM H2O2 alone or in combination with BOT (0.25 and 0.5 mg/mL). Oxidative stress markers (reactive oxygen species [ROS] and superoxide dismutase [SOD]), inflammatory cytokines (interleukin-6 [IL-6], monocyte chemoattractant protein-1 [MCP-1], and TNF-α), differentiation/functional markers (peroxisome proliferator-activated receptor gamma [Pparγ] and CCAAT/enhancer-binding protein alpha [C/ebpα] mRNA expression, adiponectin secretion, and intracellular lipid content), and glucose uptake (via a 2-deoxy-D-glucose [2-DG] assay) were evaluated. In both stages of adipocytes, H2O2 exposure significantly increased ROS levels and decreased SOD activity, and elevated extracellular IL-6, MCP-1, and TNF-α concentrations. These alterations were significantly attenuated by BOT co-treatment. Furthermore, BOT prevented the H2O2-induced downregulation of Pparγ and C/ebpα mRNA expression, thereby restoring adiponectin secretion and intracellular lipid content. Crucially, the marked impairment of 2-DG uptake caused by H2O2-mediated metabolic stress was significantly reversed by BOT co-treatment. These findings suggest that BOT exerts multi-targeted protective effects in 3T3-L1 adipocytes by mitigating oxidative stress, suppressing inflammation, and preserving adipocyte differentiation and function, thereby restoring impaired glucose uptake. Our study provides new insights into the therapeutic potential of BOT against insulin resistance and associated metabolic disorders.
- Open Access
- 20 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9310
Hangeshashinto Induces Apoptosis and Suppresses Colorectal Cancer Growth In Vitro and In Vivo
Hangeshashinto (HST) is a standardized seven-herb Kampo pharmaceutical used to manage gastrointestinal symptoms and chemotherapy-associated mucosal toxicity, but its direct antitumor activity remains insufficiently characterized. We examined the effects of HST in DLD-1 and SW480 colorectal cancer (CRC) cells and in non-malignant fibroblast and colonic epithelial cell models. Cell viability, colony formation, apoptosis-related endpoints, gene expression, responses to 5-fluorouracil (5-FU), and the activity of representative constituents were evaluated. Oral antitumor efficacy and tolerability were assessed in female BALB/c-nu mice bearing DLD-1 xenografts. HST preferentially reduced CRC cell viability and colony formation and increased annexin V positivity, caspase-3 activity, cleaved caspase-3 staining, and apoptotic nuclear changes. z-VAD-FMK showed a nonsignificant tendency toward partial recovery of cell viability. Reverse transcription–quantitative polymerase chain reaction findings were exploratory; statistical significance was not assessed. Co-treatment with HST (0.3 mg/mL) and 5-FU significantly reduced cell viability compared with 5-FU alone in both DLD-1 and SW480 cells; pharmacological synergy was not evaluated. Oral HST inhibited xenograft growth; tolerability assessment was limited to body weight and serum biochemistry, with reduced serum uric acid in the high-dose group after washout. These findings provide a preclinical basis for further investigation of standardized HST in CRC.
- 20 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9310
Open AccessHangeshashinto Induces Apoptosis and Suppresses Colorectal Cancer Growth In Vitro and In Vivo
Hangeshashinto (HST) is a standardized seven-herb Kampo pharmaceutical used to manage gastrointestinal symptoms and chemotherapy-associated mucosal toxicity, but its direct antitumor activity remains insufficiently characterized. We examined the effects of HST in DLD-1 and SW480 colorectal cancer (CRC) cells and in non-malignant fibroblast and colonic epithelial cell models. Cell viability, colony formation, apoptosis-related endpoints, gene expression, responses to 5-fluorouracil (5-FU), and the activity of representative constituents were evaluated. Oral antitumor efficacy and tolerability were assessed in female BALB/c-nu mice bearing DLD-1 xenografts. HST preferentially reduced CRC cell viability and colony formation and increased annexin V positivity, caspase-3 activity, cleaved caspase-3 staining, and apoptotic nuclear changes. z-VAD-FMK showed a nonsignificant tendency toward partial recovery of cell viability. Reverse transcription–quantitative polymerase chain reaction findings were exploratory; statistical significance was not assessed. Co-treatment with HST (0.3 mg/mL) and 5-FU significantly reduced cell viability compared with 5-FU alone in both DLD-1 and SW480 cells; pharmacological synergy was not evaluated. Oral HST inhibited xenograft growth; tolerability assessment was limited to body weight and serum biochemistry, with reduced serum uric acid in the high-dose group after washout. These findings provide a preclinical basis for further investigation of standardized HST in CRC.
- Open Access
- 8 July 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (7) , 693
Boiogito Ameliorates Inflammation-Associated Adipocyte Dysfunction and Restores Adipogenesis in Association with Suppression of NF-κB Signaling
Boiogito (BOT), a traditional Kampo herbal medicine, has been reported to exhibit anti-inflammatory and anti-obesity properties. However, its potential role in protecting adipocyte function under inflammatory conditions at different stages of adipocyte development remains unclear. This study investigated the effects of BOT on adipogenesis and tumor necrosis factor-α (TNF-α)-induced inflammatory responses in differentiating and mature 3T3-L1 adipocytes. In this study, 3T3-L1 preadipocytes were induced to differentiate and exposed to TNF-α in the presence or absence of BOT during differentiation or after full adipocyte maturation. Lipid accumulation was assessed by Oil Red O staining, while adipokine secretion and inflammatory cytokine production were evaluated by ELISA. The expression of adipogenic markers and inflammatory signaling molecules was analyzed using quantitative PCR and Western blotting. TNF-α significantly inhibited the expression of adipogenesis-related factors at the transcriptional level in adipocytes, reduced lipid accumulation and adiponectin expression, and enhanced inflammatory cytokine production. BOT treatment dose-dependently attenuated these effects, restoring adipogenic capacity and suppressing inflammatory responses in both differentiating and mature adipocytes. Mechanistically, BOT reduced TNF-α-induced activation of the NF-κB pathway, as evidenced by decreased phosphorylation of NF-κB p65 and IκB. These findings demonstrate that BOT preserves adipocyte function and mitigates inflammation-associated adipocyte dysfunction throughout adipocyte development. The protective effects of BOT may contribute to the regulation of obesity-associated metabolic inflammation, partly through modulation of NF-κB signaling.
- 8 July 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (7) , 693
Open AccessBoiogito Ameliorates Inflammation-Associated Adipocyte Dysfunction and Restores Adipogenesis in Association with Suppression of NF-κB Signaling
Boiogito (BOT), a traditional Kampo herbal medicine, has been reported to exhibit anti-inflammatory and anti-obesity properties. However, its potential role in protecting adipocyte function under inflammatory conditions at different stages of adipocyte development remains unclear. This study investigated the effects of BOT on adipogenesis and tumor necrosis factor-α (TNF-α)-induced inflammatory responses in differentiating and mature 3T3-L1 adipocytes. In this study, 3T3-L1 preadipocytes were induced to differentiate and exposed to TNF-α in the presence or absence of BOT during differentiation or after full adipocyte maturation. Lipid accumulation was assessed by Oil Red O staining, while adipokine secretion and inflammatory cytokine production were evaluated by ELISA. The expression of adipogenic markers and inflammatory signaling molecules was analyzed using quantitative PCR and Western blotting. TNF-α significantly inhibited the expression of adipogenesis-related factors at the transcriptional level in adipocytes, reduced lipid accumulation and adiponectin expression, and enhanced inflammatory cytokine production. BOT treatment dose-dependently attenuated these effects, restoring adipogenic capacity and suppressing inflammatory responses in both differentiating and mature adipocytes. Mechanistically, BOT reduced TNF-α-induced activation of the NF-κB pathway, as evidenced by decreased phosphorylation of NF-κB p65 and IκB. These findings demonstrate that BOT preserves adipocyte function and mitigates inflammation-associated adipocyte dysfunction throughout adipocyte development. The protective effects of BOT may contribute to the regulation of obesity-associated metabolic inflammation, partly through modulation of NF-κB signaling.
- Open Access
Shoseiryuto May Prevent Bronchial Epithelial Tight Junction Disruption by Inhibiting the Inflammatory NF-κB Signaling Pathway
Shoseiryuto (SST) is a Kampo medicine widely used to treat respiratory diseases. We previously showed that SST attenuates lipopolysaccharide (LPS)-induced tight junction (TJ) barrier disruption in human bronchial epithelial (16HBE) cells. However, the underlying mechanisms remain unclear. This study aimed to clarify the mechanisms underlying the protective effects of SST. SST attenuated inflammatory responses (increased IL-6 protein and mRNA levels) and TJ disruption (decreased transepithelial electrical resistance, increased sodium fluorescein permeability, and decreased occludin mRNA and protein expression) induced by LPS, hydrogen peroxide (H2O2), tumor necrosis factor-α (TNF-α), and polyinosinic–polycytidylic acid (Poly I:C). Further analyses using the Poly I:C model confirmed that the effects of SST were comparable to those of the nuclear factor κB (NF-κB) inhibitors SC-514 and BAY11-7085. SST reduced the activation of NF-κB signaling (increased phosphorylation of NF-κB and IκB), similar to BAY11-7085. SST components, isoliquiritigenin (ILQG) and glycyrrhizin (GL), also attenuated inflammation, barrier dysfunction, and NF-κB signaling activity. These findings suggest that (1) activation of the NF-κB signaling pathway might be associated with both inflammatory responses and TJ barrier disruption; (2) SST could reduce these effects, potentially through modulation of NF-κB signaling; and (3) ILQG and GL may contribute, in part, to these activities. Overall, this study provides the first evidence suggesting that SST may exert anti-inflammatory and epithelial barrier-protective effects, possibly via the suppression of the NF-κB signaling pathway.
Open AccessShoseiryuto May Prevent Bronchial Epithelial Tight Junction Disruption by Inhibiting the Inflammatory NF-κB Signaling Pathway
Shoseiryuto (SST) is a Kampo medicine widely used to treat respiratory diseases. We previously showed that SST attenuates lipopolysaccharide (LPS)-induced tight junction (TJ) barrier disruption in human bronchial epithelial (16HBE) cells. However, the underlying mechanisms remain unclear. This study aimed to clarify the mechanisms underlying the protective effects of SST. SST attenuated inflammatory responses (increased IL-6 protein and mRNA levels) and TJ disruption (decreased transepithelial electrical resistance, increased sodium fluorescein permeability, and decreased occludin mRNA and protein expression) induced by LPS, hydrogen peroxide (H2O2), tumor necrosis factor-α (TNF-α), and polyinosinic–polycytidylic acid (Poly I:C). Further analyses using the Poly I:C model confirmed that the effects of SST were comparable to those of the nuclear factor κB (NF-κB) inhibitors SC-514 and BAY11-7085. SST reduced the activation of NF-κB signaling (increased phosphorylation of NF-κB and IκB), similar to BAY11-7085. SST components, isoliquiritigenin (ILQG) and glycyrrhizin (GL), also attenuated inflammation, barrier dysfunction, and NF-κB signaling activity. These findings suggest that (1) activation of the NF-κB signaling pathway might be associated with both inflammatory responses and TJ barrier disruption; (2) SST could reduce these effects, potentially through modulation of NF-κB signaling; and (3) ILQG and GL may contribute, in part, to these activities. Overall, this study provides the first evidence suggesting that SST may exert anti-inflammatory and epithelial barrier-protective effects, possibly via the suppression of the NF-κB signaling pathway.
- Open Access
Protective Effects of Centella asiatica Against Senescence and Apoptosis in Epidermal Cells
Centella asiatica, a traditional medicinal plant, possesses potent antioxidant activity and may therefore prevent cellular aging and exert antiapoptotic effects. However, these effects remain to be fully elucidated. This study aimed to investigate the protective effects of C. asiatica extract against cellular senescence and apoptosis caused by hydrogen peroxide (H2O2)-induced oxidative stress in human epidermal keratinocytes (HaCaT cells). To evaluate the effects of H2O2 and C. asiatica on HaCaT cells, we measured cell viability as a marker of cell death; reactive oxygen species (ROS), radical scavenging, superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase activities as markers of oxidative stress; senescence-associated β-galactosidase (SA-β-gal) activity as a marker of cellular senescence; and caspase-3/9 activities and apoptotic cells as markers of apoptosis. H2O2 induced cell death (decreased cell viability), oxidative stress (increased ROS activity, decreased radical scavenging, SOD, GPx, and catalase activities), cellular senescence (increased SA-β-gal activity), and apoptosis (increased early/late apoptotic cells and increased caspase-3/9 activities). C. asiatica significantly decreased all markers of H2O2-induced cell death, oxidative stress, cellular senescence, and apoptosis, suggesting its ability to prevent cellular senescence and apoptosis through its antioxidant activity. This mechanism of action may contribute to the prevention and improvement of skin aging.
Open AccessProtective Effects of Centella asiatica Against Senescence and Apoptosis in Epidermal Cells
Centella asiatica, a traditional medicinal plant, possesses potent antioxidant activity and may therefore prevent cellular aging and exert antiapoptotic effects. However, these effects remain to be fully elucidated. This study aimed to investigate the protective effects of C. asiatica extract against cellular senescence and apoptosis caused by hydrogen peroxide (H2O2)-induced oxidative stress in human epidermal keratinocytes (HaCaT cells). To evaluate the effects of H2O2 and C. asiatica on HaCaT cells, we measured cell viability as a marker of cell death; reactive oxygen species (ROS), radical scavenging, superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase activities as markers of oxidative stress; senescence-associated β-galactosidase (SA-β-gal) activity as a marker of cellular senescence; and caspase-3/9 activities and apoptotic cells as markers of apoptosis. H2O2 induced cell death (decreased cell viability), oxidative stress (increased ROS activity, decreased radical scavenging, SOD, GPx, and catalase activities), cellular senescence (increased SA-β-gal activity), and apoptosis (increased early/late apoptotic cells and increased caspase-3/9 activities). C. asiatica significantly decreased all markers of H2O2-induced cell death, oxidative stress, cellular senescence, and apoptosis, suggesting its ability to prevent cellular senescence and apoptosis through its antioxidant activity. This mechanism of action may contribute to the prevention and improvement of skin aging.
- Open Access
- 1 January 2023
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2023 (1) , 4694243
Shoseiryuto Promotes the Formation of a Tight‐Junction Barrier in Cultured Human Bronchial Epithelial Cells
Shoseiryuto (SST) (Xiao‐Qing‐Long‐Tang in Chinese) is an effective treatment for respiratory diseases, such as bronchial asthma and allergic rhinitis, but its effects on the bronchial tight‐junction (TJ) barrier have not been clarified. This study aimed to evaluate the effect of SST on TJ‐barrier function in human bronchial epithelial (16HBE) cells. The 16HBE cells were cultured in a culture medium without (control) and with SST in the absence and presence of bacterial endotoxin lipopolysaccharide (LPS) in transwell chambers. Transepithelial electrical resistance (TEER) and sodium fluorescein (Na‐F) permeability of the cultured‐cell monolayer were measured as TJ integrity markers. In addition, immunofluorescence staining and quantitative real‐time polymerase chain reaction analysis were used to measure the expression of the TJ protein, occludin. SST increased TEER and decreased Na‐F permeability of the 16HBE cell monolayers. Furthermore, SST increased both occludin mRNA and immunostained protein expressions, suggesting that SST has the effect of directly promoting epithelial TJ‐barrier function. LPS decreased TEER, increased Na‐F permeability, and decreased both occludin mRNA and protein expression. LPS‐induced barrier dysfunction was completely blocked by pre/co‐ and posttreatment with SST. These results suggest that SST has protective and therapeutic effects against LPS‐induced TJ‐barrier damage. To our knowledge, these are the first results to demonstrate the protective and therapeutic effects conferred by TJ‐barrier promoting, which may be a novel mechanism contributing to the efficacy of SST for respiratory diseases.
- 1 January 2023
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2023 (1) , 4694243
Open AccessShoseiryuto Promotes the Formation of a Tight‐Junction Barrier in Cultured Human Bronchial Epithelial Cells
Shoseiryuto (SST) (Xiao‐Qing‐Long‐Tang in Chinese) is an effective treatment for respiratory diseases, such as bronchial asthma and allergic rhinitis, but its effects on the bronchial tight‐junction (TJ) barrier have not been clarified. This study aimed to evaluate the effect of SST on TJ‐barrier function in human bronchial epithelial (16HBE) cells. The 16HBE cells were cultured in a culture medium without (control) and with SST in the absence and presence of bacterial endotoxin lipopolysaccharide (LPS) in transwell chambers. Transepithelial electrical resistance (TEER) and sodium fluorescein (Na‐F) permeability of the cultured‐cell monolayer were measured as TJ integrity markers. In addition, immunofluorescence staining and quantitative real‐time polymerase chain reaction analysis were used to measure the expression of the TJ protein, occludin. SST increased TEER and decreased Na‐F permeability of the 16HBE cell monolayers. Furthermore, SST increased both occludin mRNA and immunostained protein expressions, suggesting that SST has the effect of directly promoting epithelial TJ‐barrier function. LPS decreased TEER, increased Na‐F permeability, and decreased both occludin mRNA and protein expression. LPS‐induced barrier dysfunction was completely blocked by pre/co‐ and posttreatment with SST. These results suggest that SST has protective and therapeutic effects against LPS‐induced TJ‐barrier damage. To our knowledge, these are the first results to demonstrate the protective and therapeutic effects conferred by TJ‐barrier promoting, which may be a novel mechanism contributing to the efficacy of SST for respiratory diseases.